Pregnancy is characterized by reduced insulin sensitivity, which can advance to gestational diabetes in at-risk individuals. Identifying early predictors of GDM would help pregnancy outcomes by improving the time to intervention in this group.

Objective: To test body composition measures as potential early predictors of gestational insulin resistance.

Methods: At 19-20 weeks gestation, 32 nulliparous women (aged 27.2± 4.5 yrs) received body composition measures including percent body fat (PBF), fat and lean mass by bioimpedance; abdominal adipose via ultrasound (intra-abdominal, IAAT; subcutaneous, SAT); and skinfolds. Homeostasis assessment model of insulin resistance (HOMA-IR) was calculated from fasting glucose and insulin at 24-26 weeks and log-transformed for normality. Missing data was imputed by linear trend. One individual was excluded due to extreme BMI (>50). RESULTS: In analyses controlled for age and race, pre-pregnancy BMI and most measures of overall and regional body composition were associated with HOMA-IR (BMI: r=.523; PBF: r=.481; IAAT: r=.421; SAT: r=.611; fat mass: r=.569; lean mass: r=.434; p<.05 for all). In a regression model with age, race, and lean mass, fat mass was the only significant predictor of HOMA-IR (Model: R2= .345, p=.022; Fat Mass: Std. β= .501, p=.025; Lean Mass: β= .131, p=.535). Replacing lean mass with IAAT and SAT improved the association with HOMA-IR (Model R2=.559, p=.004), with SAT as the only significant predictor (β =.479, p<.01). Skinfold measures did not improve the model or achieve significance.

Conclusion: Body composition measures, especially SAT, may serve as potential early predictors of gestational insulin resistance. Adopting such early predictors may have a significant impact on maternal health by facilitating the implementation of earlier interventions for metabolic health.

Disclosure

K. Ingram: Stock/Shareholder; Eli Lilly and Company, Novo Nordisk, AstraZeneca, Dexcom, Inc. A. Eho: None. B. McDonald: None. J. Amason: None.

Funding

National Institutes of Health (3R15HD102957-01S1)

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.